Unavailable
Unavailable
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 8/23/2024 | $21.00 | Buy | B. Riley Securities |
| 10/12/2022 | $24.00 | Hold | Jefferies |
10-Q - Varex Imaging Corp (0001681622) (Filer)
8-K - Varex Imaging Corp (0001681622) (Filer)
SCHEDULE 13G/A - Varex Imaging Corp (0001681622) (Subject)
B. Riley Securities initiated coverage of Varex Imaging with a rating of Buy and set a new price target of $21.00
Jefferies initiated coverage of Varex Imaging with a rating of Hold and set a new price target of $24.00
Oppenheimer upgraded Varex Imaging from Market Perform to Outperform and set a new price target of $35.50
Varex Imaging Corporation (NASDAQ:VREX) announced today that management is scheduled to present at the Jefferies Global Healthcare Conference in New York. Management will participate in a fireside chat presentation on Wednesday, June 3, 2026 at 3:10 pm ET. The presentation will be webcast and can be accessed here or on Varex's website at www.vareximaging.com/news. About Varex Varex Imaging Corporation is a leading innovator, designer, and manufacturer of X-ray imaging components, which include X-ray tubes, digital detectors, and other image processing solutions that are key components of X-ray imaging systems, as well as X-ray imaging systems for industrial applications. With a 70+ ye
Varex Imaging Corporation (NASDAQ:VREX) today announced its unaudited financial results for the second quarter fiscal year 2026. Q2FY26 Summary Revenues $216 million GAAP gross margin 34% | Non-GAAP gross margin* 34% GAAP operating margin 7% | Non-GAAP operating margin* 9% GAAP net loss $0.19 per diluted share | Non-GAAP net income* $0.21 per diluted share Cash outflows from operations of $2 million "Demand remained solid in the second quarter, with continued momentum across both our Medical and Industrial businesses driven by global CT, cargo systems and photon counting detectors," said Sunny Sanyal, Chief Executive Officer. Sanyal added, "As we move into the second hal
Varex Imaging Corporation (NASDAQ:VREX) today announced that it will report unaudited financial results for the second quarter of fiscal year 2026, following the close of regular trading on Thursday, May 7, 2026. The earnings news release will be followed by a conference call at 3:00 pm Mountain Time that day. This call will be webcast live and can be accessed at the company's website at www.vareximaging.com/investor-relations/. Investors can also access this conference call at 877-524-8416 from anywhere in the U.S. or 412-902-1028 from non-U.S. locations. The webcast of this call will be archived on the company's website and a replay of the call will be available from May 7th through May
3 - Varex Imaging Corp (0001681622) (Issuer)
3 - Varex Imaging Corp (0001681622) (Issuer)
4 - Varex Imaging Corp (0001681622) (Issuer)
4 - Varex Imaging Corp (0001681622) (Issuer)
4 - Varex Imaging Corp (0001681622) (Issuer)
SAN RAMON, Calif., Dec. 23, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (NASDAQ:COO), a leading medical device company, announced today that the Company's Board of Directors (the "Board") has appointed Walter (Walt) M Rosebrough, Jr. as an independent director, effective as of January 3, 2026. In connection with this appointment, the Company also has entered into a cooperation agreement (the "Cooperation Agreement") with Browning West, LP. ("Browning West"). Mr. Rosebrough will join the Board's Corporate Governance & Nominating Committee. The Board has also agreed that, by the end of 2026, it shall provide due and serious consideration for Mr. Rosebrough to be appointed Chair of the Board. In
NEW YORK, Sept. 6, 2024 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, September 23, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range. All companies being added to the S&P 500 are more representative of the large-cap market space, all companies being added to the S&P MidCap 400 are more representative of the mid-cap market space, and all companies being added to the S&P SmallCap 600 are more representative of the small-cap market space. The companies being removed from
SC 13G/A - Varex Imaging Corp (0001681622) (Subject)
SC 13G/A - Varex Imaging Corp (0001681622) (Subject)
SC 13G/A - Varex Imaging Corp (0001681622) (Subject)
Varex Imaging Corporation (NASDAQ:VREX) today announced its unaudited financial results for the second quarter fiscal year 2026. Q2FY26 Summary Revenues $216 million GAAP gross margin 34% | Non-GAAP gross margin* 34% GAAP operating margin 7% | Non-GAAP operating margin* 9% GAAP net loss $0.19 per diluted share | Non-GAAP net income* $0.21 per diluted share Cash outflows from operations of $2 million "Demand remained solid in the second quarter, with continued momentum across both our Medical and Industrial businesses driven by global CT, cargo systems and photon counting detectors," said Sunny Sanyal, Chief Executive Officer. Sanyal added, "As we move into the second hal
Varex Imaging Corporation (NASDAQ:VREX) today announced that it will report unaudited financial results for the second quarter of fiscal year 2026, following the close of regular trading on Thursday, May 7, 2026. The earnings news release will be followed by a conference call at 3:00 pm Mountain Time that day. This call will be webcast live and can be accessed at the company's website at www.vareximaging.com/investor-relations/. Investors can also access this conference call at 877-524-8416 from anywhere in the U.S. or 412-902-1028 from non-U.S. locations. The webcast of this call will be archived on the company's website and a replay of the call will be available from May 7th through May
Varex Imaging Corporation (NASDAQ:VREX) today announced its unaudited financial results for the first quarter fiscal year 2026. Q1FY26 Summary Revenues $210 million GAAP gross margin 33% | Non-GAAP gross margin* 34% GAAP operating margin 7% | Non-GAAP operating margin* 9% GAAP net income $0.05 per diluted share | Non-GAAP net income* $0.19 per diluted share Cash outflow from operations of $16 million "We are pleased to report a solid start to fiscal 2026, with results toward the high-end of guidance. First quarter revenue of $210 million, increased 5% year-over-year. Growth in the quarter was driven by strength in our cargo systems business, which contributed to a 17% ye